Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 3Colonic Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Disease Progression 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

tremelimumab 1pembrolizumab 1grapiprant 1durvalumab 1cemiplimab 1brigatinib 1binimetinib 1Thioctic Acid 1Standard of Care 1Sevoflurane 1Propofol 1Practice Guidelines as Topic 1Pemetrexed 1Palliative Care 1Paclitaxel 1Interleukin-2 1Gemcitabine 1Drug Therapy 1Cisplatin 1Carboplatin 1Anesthesia, Inhalation 1AZD 6244 13-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Sevoflurane × Thoracic × Clear all
NCT05663242 2023-05-30

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Recruiting
300 enrolled
Thoracic

Lung Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡